September 17, 2019
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
Read More
September 17, 2019
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)
Read More
September 15, 2019
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Read More
September 15, 2019
EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients
Read More
September 15, 2019
Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
Read More
September 14, 2019
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Read More
September 14, 2019
Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Read More
September 14, 2019
Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)
Read More
September 14, 2019
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With Non-central GA
Read More
September 14, 2019
LN-145 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
Read More
September 14, 2019
Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
Read More
September 14, 2019
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Read More
Load More
X